Physicochemical characteristics of pentamidine-loaded polymethacrylate nanoparticles: implication in the intracellular drug release in Leishmania major infected mice.
about
Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticlesNanomedicine in the diagnosis and therapy of neurodegenerative disorders.Novel arylimidamides for treatment of visceral leishmaniasis.Delivery strategies for antiparasitics.Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses.Drug delivery systems in the treatment of African trypanosomiasis infections.Polymeric colloidal particulate systems: intelligent tools for intracellular targeting of antileishmanial cargos.Drug delivery: lessons to be learnt from Leishmania studies.Investigational drugs for visceral leishmaniasis.Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improved in vitro and in vivo effect in leishmaniasis.Enhanced cytotoxicity of optimized liposomal genistein via specific induction of apoptosis in breast, ovarian and prostate carcinomas.Evaluation of nanoparticles as endocytic tracers in cellular microbiology.Development of doxorubicin loaded novel core shell structured nanocapsules for the intervention of visceral leishmaniasis.Intracellular drug delivery in Leishmania-infected macrophages: Evaluation of saponin-loaded PLGA nanoparticles.Drug targeting to macrophages using paromomycin-loaded albumin microspheres for treatment of visceral leishmaniasis: an in vitro evaluation.Evaluation of (131)I-pentamidine for scintigraphy of experimentally Leishmania tropica-infected hamsters.Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis.
P2860
Q28474651-22C44A48-618A-458B-8EE1-3195FB7F9C27Q33726019-05EF487B-70A8-4675-9BA5-4410D91CEE69Q33876693-2FA3EFDE-54F5-47D2-B702-98A16C07A88BQ35056056-42D1E21C-FB92-442A-B244-E14EBC33100BQ37436554-A5F4A01F-F685-4056-A1CC-D27A08E168CAQ37876880-511B1007-0C95-4C0F-99D3-49820ECE295AQ38154629-7A52C3EF-52D5-4DF8-A94B-5E4FC9540136Q38254087-3C566A74-6B00-4797-A0F8-96C10AFC7C15Q38269581-BD180F13-AA8F-49E7-B116-59A7F16A25D2Q39017657-B10A873D-5E1D-4554-A882-D754FE4FFFF6Q39073033-FA91A849-30A3-4645-BAA2-6F42D0146F81Q39110597-B2E413E0-6461-43B3-8975-4639F63766A5Q39174889-8C92536B-2696-4D65-9226-F84B804512C4Q39443647-399BF00A-A833-4E05-A430-7EB62337E171Q39693592-1DE91EC2-D950-4940-8C61-1AF3EBA4BC4BQ44458026-D8D0DB94-0ED7-400C-954D-819FFE8AC109Q46612371-927C182C-9292-437A-95E1-B14672026C05
P2860
Physicochemical characteristics of pentamidine-loaded polymethacrylate nanoparticles: implication in the intracellular drug release in Leishmania major infected mice.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Physicochemical characteristic ...... eishmania major infected mice.
@en
Physicochemical characteristic ...... eishmania major infected mice.
@nl
type
label
Physicochemical characteristic ...... eishmania major infected mice.
@en
Physicochemical characteristic ...... eishmania major infected mice.
@nl
prefLabel
Physicochemical characteristic ...... eishmania major infected mice.
@en
Physicochemical characteristic ...... eishmania major infected mice.
@nl
P2093
P2860
P1476
Physicochemical characteristic ...... eishmania major infected mice.
@en
P2093
Fernandez C
Rivollet D
P2860
P304
P356
10.3109/10611869808997874
P577
1998-01-01T00:00:00Z